Takeda Pharmaceutical Co Ltd - Company Profile

Powered by

All the sales intelligence you need on Takeda Pharmaceutical Co Ltd in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Takeda Pharmaceutical Co Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Takeda Pharmaceutical Co Ltd.

Back to companies

Takeda Pharmaceutical Co Ltd: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Takeda Pharmaceutical Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Takeda Pharmaceutical Co Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Julie Kim

Director; President; Chief Executive Officer Executive Board Since: 2026

Mrs. Julie Kim has been the Chief Executive Officer, Director, and President of the company since June 2026. Previously, she served as Head of the U.S. Business Unit of the company.

Read Hide full bio of Julie Kim

Milano Furuta

Director; Chief Financial Officer Executive Board Since: 2024 Age: 48

Mr. Milano Furuta has been the Director and Chief Financial Officer of the company since 2024. Prior to this, he served as the President of Takeda’s Japan Pharma Business Unit from April 2021 to March 2024. Mr. Furuta also served as the Corporate Strategy Officer and Chief Of Staff at Takeda. Previously, he served as an Equity Research Analyst at an investment management firm in the US.

Read Hide full bio of Milano Furuta

Gabriele Ricci

Chief Technology Officer; Chief Data Officer Senior Management Since: 2022 Age: 48

Mr. Gabriele Ricci has been the Chief Data Officer and Chief Technology Officer of the company since 2022. Prior to this, he served as the Head of IT for the Plasma-Derived Therapies Business Unit. Previously, he served as the Head of Technical Operations at Shire.

Read Hide full bio of Gabriele Ricci

Takako Ohyabu

Chief Corporate Affairs Officer; Chief Sustainability Officer Senior Management Since: 2019 Age: 47

Ms. Takako Ohyabu has been the Chief Corporate Affairs Officer and Chief Sustainability Officer of the company since 2019. Prior to this, she served as the Chief Communications and Public Affairs Officer Designate of the company. Ms. Ohyabu also served as the Global Corporate Communications Function at Nissan Motor Corporation.

Read Hide full bio of Takako Ohyabu

Mwana Lugogo

Chief Compliance Officer; Chief Ethics Officer Senior Management Since: 2019 Age: 56

Ms. Mwana Lugogo has been the Chief Ethics Officer and Chief Compliance Officer of the company since 2019. Prior to this, she served as the Head of Compliance Emerging Markets of Takeda Pharmaceuticals International GmBh. Previously, she served as the Senior Counsel of Baxter Healthcare.

Read Hide full bio of Mwana Lugogo
Gain a 360-degree view of Takeda Pharmaceutical Co Ltd and make more informed decisions for your business Gain a 360-degree view of Takeda Pharmaceutical Co Ltd and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer